AML with germline DDX41 variants is a clinicopathologically distinct entity with an indolent clinical course and favorable outcome

Journal

  • Leukemia

    Leukemia 36 (3), 664-674, 2021-10-20

    Springer Science and Business Media LLC

Citations (8)*help

See more

Report a problem

Back to top